Billionaire Profile
Cao Longxiang & family
Global Rank
#1542

Image: Unsplash Contributor | Unsplash License | via Unsplash

Cao Longxiang & family

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$2.761B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-0.23% (24h)
Age
68
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Cao Longxiang, at 68 years old, chairs Hubei Jumpcan Pharmaceutical, a leading pharmaceutical company in China specializing in both Western and traditional Chinese medicine. His journey began after serving in the Chinese military and working as a manager in a cement factory. Cao took control of the company in 2013, after it went public in 2001, and now owns more than 60% of the company. His wealth stems from the pharmaceutical industry, and his estimated net worth is $3.0 billion as of 2024.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Cao Longxiang's early life included service in the Chinese military, followed by a role as a manager in a cement factory. This diverse background provided him with a unique perspective and skills that would later prove valuable in the business world.

Rise to Success

Cao's path to becoming a billionaire began with his involvement in the pharmaceutical industry. He chairs Hubei Jumpcan Pharmaceutical, one of China's largest drug companies. He took control of Hubei Jumpcan Pharmaceutical, after it went public, now owning more than 60% of the company.

Key Business Strategies

Under Cao's leadership, Hubei Jumpcan Pharmaceutical has focused on both Western and traditional Chinese medicine, showcasing a commitment to a diversified approach within the pharmaceutical sector.

Philanthropy

Unfortunately, specific details regarding Cao Longxiang's philanthropy are not readily available in the search results. Further research would be needed to uncover specific initiatives and amounts.

Career Milestones

2013

Took control of Hubei Jumpcan Pharmaceutical

Cao Longxiang took control of Hubei Jumpcan Pharmaceutical after the company went public in 2001